Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 101

Similar articles for PubMed (Select 21884576)

1.

Identification of improved IL28B SNPs and haplotypes for prediction of drug response in treatment of hepatitis C using massively parallel sequencing in a cross-sectional European cohort.

Smith KR, Suppiah V, O'Connor K, Berg T, Weltman M, Abate ML, Spengler U, Bassendine M, Matthews G, Irving WL, Powell E, Riordan S, Ahlenstiel G, Stewart GJ, Bahlo M, George J, Booth DR; International Hepatitis C Genetics Consortium (IHCGC).

Genome Med. 2011 Aug 31;3(8):57. doi: 10.1186/gm273.

2.

IL28B, HLA-C, and KIR variants additively predict response to therapy in chronic hepatitis C virus infection in a European Cohort: a cross-sectional study.

Suppiah V, Gaudieri S, Armstrong NJ, O'Connor KS, Berg T, Weltman M, Abate ML, Spengler U, Bassendine M, Dore GJ, Irving WL, Powell E, Hellard M, Riordan S, Matthews G, Sheridan D, Nattermann J, Smedile A, Müller T, Hammond E, Dunn D, Negro F, Bochud PY, Mallal S, Ahlenstiel G, Stewart GJ, George J, Booth DR; International Hepatitis C Genetics Consortium (IHCGC).

PLoS Med. 2011 Sep;8(9):e1001092. doi: 10.1371/journal.pmed.1001092. Epub 2011 Sep 13.

3.

The predictive value of IL28B rs12979860, rs11881222 and rs8099917 polymorphisms and IP-10 in the therapeutic response of Egyptian genotype 4 patients.

Derbala M, Rizk NM, Al-Kaabi S, John A, Sharma M, El-dweik N, Yakoob R, Pasic F, Almohanadi M, Alejji K, Abdelmola A, Butt M.

Virology. 2013 Sep;444(1-2):292-300. doi: 10.1016/j.virol.2013.06.025. Epub 2013 Jul 16.

4.

IL28B polymorphism genotyping as predictor of rapid virologic response during interferon plus ribavirin treatment in hepatitis C virus genotype 1 patients.

Rosso C, Abate ML, Ciancio A, Strona S, Caviglia GP, Olivero A, Touscoz GA, Rizzetto M, Pellicano R, Smedile A.

World J Gastroenterol. 2014 Sep 28;20(36):13146-52. doi: 10.3748/wjg.v20.i36.13146.

5.

Strong prediction of virological response to combination therapy by IL28B gene variants rs12979860 and rs8099917 in chronic hepatitis C genotype 4.

Ragheb MM, Nemr NA, Kishk RM, Mandour MF, Abdou MM, Matsuura K, Watanabe T, Tanaka Y.

Liver Int. 2014 Jul;34(6):890-5. doi: 10.1111/liv.12321. Epub 2013 Oct 14.

PMID:
24102823
6.

Deciphering the interleukin 28B variants that better predict response to pegylated interferon-α and ribavirin therapy in HCV/HIV-1 coinfected patients.

de Castellarnau M, Aparicio E, Parera M, Franco S, Tural C, Clotet B, Martínez MA.

PLoS One. 2012;7(2):e31016. doi: 10.1371/journal.pone.0031016. Epub 2012 Feb 6.

7.

Rs12979860 and rs8099917 single nucleotide polymorphisms of interleukin-28B gene: simultaneous genotyping in caucasian patients infected with hepatitis C virus.

Sticchi L, Di Biagio A, Rappazzo E, Setti M, De Rosa G, De Hoffer L, Nicolini L, Prinapori R, Bruzzone B.

J Prev Med Hyg. 2013 Jun;54(2):83-6.

PMID:
24396987
8.

Combined effects of different interleukin-28B gene variants on the outcome of dual combination therapy in chronic hepatitis C virus type 1 infection.

Fischer J, Böhm S, Scholz M, Müller T, Witt H, George J, Sarrazin C, Susser S, Schott E, Suppiah V, Booth DR, Stewart GJ, van Bömmel F, Brodzinski A, Fülöp B, Migaud P, Berg T.

Hepatology. 2012 Jun;55(6):1700-10. doi: 10.1002/hep.25582. Epub 2012 Apr 18.

PMID:
22234924
9.

Development and Validation of a Simple, Rapid and Inexpensive PCR-RFLP Method for Genotyping of Common IL28B Polymorphisms: A Useful Pharmacogenetic Tool for Prediction of Hepatitis C Treatment Response.

Sharafi H, Pouryasin A, Alavian SM, Behnava B, Keshvari M, Mehrnoush L, Salimi S, Kheradvar O.

Hepat Mon. 2012 Mar;12(3):190-5. doi: 10.5812/hepatmon.849. Epub 2012 Mar 28.

10.

IL28B genetic variation and treatment response in patients with hepatitis C virus genotype 3 infection.

Moghaddam A, Melum E, Reinton N, Ring-Larsen H, Verbaan H, Bjøro K, Dalgard O.

Hepatology. 2011 Mar;53(3):746-54. doi: 10.1002/hep.24154.

PMID:
21374656
11.

No association between the IL28B SNP and response to peginterferon plus ribavirin combination treatment in Korean chronic hepatitis C patients.

Heo NY, Lim YS, Lee W, Oh M, An J, Lee D, Shim JH, Kim KM, Lee HC, Lee YS, Suh DJ.

Clin Mol Hepatol. 2014 Jun;20(2):177-84. doi: 10.3350/cmh.2014.20.2.177. Epub 2014 Jun 30.

12.

Association of two polymorphisms of the IL28B gene with viral factors and treatment response in 1,518 patients infected with hepatitis C virus.

Kobayashi M, Suzuki F, Akuta N, Sezaki H, Suzuki Y, Hosaka T, Kawamura Y, Kobayashi M, Saitoh S, Arase Y, Ikeda K, Chayama K, Miyakawa Y, Kumada H.

J Gastroenterol. 2012 May;47(5):596-605. doi: 10.1007/s00535-012-0531-1. Epub 2012 Mar 23.

PMID:
22438096
13.

A single IL28B genotype SNP rs12979860 determination predicts treatment response in patients with chronic hepatitis C Genotype 1 virus.

Halfon P, Bourliere M, Ouzan D, Maor Y, Renou C, Wartelle C, Pénaranda G, Tran A, Botta D, Oules V, Castellani P, Portal I, Argiro L, Dessein A.

Eur J Gastroenterol Hepatol. 2011 Oct;23(10):931-5. doi: 10.1097/MEG.0b013e328349d0ef.

PMID:
21900787
14.

Genetic variant of IL28B rs12979860, as predictive marker of interferon-based therapy in Pakistani population.

Imran M, Manzoor S, Azam S, Resham S.

APMIS. 2015 Apr;123(4):342-9. doi: 10.1111/apm.12365. Epub 2015 Feb 20.

PMID:
25703417
15.

Predictive value of interferon-lambda gene polymorphisms for treatment response in chronic hepatitis C.

Susser S, Herrmann E, Lange C, Hamdi N, Müller T, Berg T, Perner D, Zeuzem S, Sarrazin C.

PLoS One. 2014 Nov 13;9(11):e112592. doi: 10.1371/journal.pone.0112592. eCollection 2014.

16.

IL28B SNP rs12979860 is a critical predictor for on-treatment and sustained virologic response in patients with hepatitis C virus genotype-1 infection.

Lin CY, Chen JY, Lin TN, Jeng WJ, Huang CH, Huang CW, Chang SW, Sheen IS.

PLoS One. 2011 Mar 30;6(3):e18322. doi: 10.1371/journal.pone.0018322.

17.

Impact of host IL28B rs12979860, rs8099917 in interferon responsiveness and advanced liver disease in chronic genotype 3 hepatitis C patients.

Firdaus R, Biswas A, Saha K, Mukherjee A, Chaudhuri S, Chandra A, Konar A, Sadhukhan PC.

PLoS One. 2014 Jun 10;9(6):e99126. doi: 10.1371/journal.pone.0099126. eCollection 2014.

18.

Sequence analysis of the IL28A/IL28B inverted gene duplication that contains polymorphisms associated with treatment response in hepatitis C patients.

Reynolds JM, Paciga SA, Sanders FA, Hyde CL, Loomis AK, Johnston GI.

PLoS One. 2012;7(1):e29983. doi: 10.1371/journal.pone.0029983. Epub 2012 Jan 10.

19.

Interleukin 28B-related polymorphisms: a pathway for understanding hepatitis C virus infection?

Garcia RF, Moreira S, de Araújo Ramos AL, Ferreira LE, de Mattos AA, Tovo CV, Nader LA, Ramos JA, Rondinelli E, de Jesus Dominici A, Garcia CE, de Souza Leite Pinho M, Brandão-Mello CE, Villela-Nogueira CA, de França PH.

World J Gastroenterol. 2013 Nov 14;19(42):7399-404. doi: 10.3748/wjg.v19.i42.7399.

20.

Test of IL28B polymorphisms in chronic hepatitis C patients treated with PegIFN and ribavirin depends on HCV genotypes: results from a meta-analysis.

Jia Z, Ding Y, Tian S, Niu J, Jiang J.

PLoS One. 2012;7(9):e45698. doi: 10.1371/journal.pone.0045698. Epub 2012 Sep 21.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk